z-logo
open-access-imgOpen Access
Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal form
Author(s) -
Vaishali Sahasrabudhe,
Kyle Matschke,
Haihong Shi,
Anne Hickman,
Angela Kong,
Barbara Rodríguez Spong,
Beverly Nickerson,
Kapildev K. Arora
Publication year - 2022
Publication title -
international journal of clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.363
H-Index - 67
ISSN - 0946-1965
DOI - 10.5414/cp204212
Subject(s) - cocrystal , bioequivalence , dosage form , amorphous solid , bioavailability , chromatography , chemistry , crossover study , pharmacology , medicine , organic chemistry , placebo , molecule , hydrogen bond , alternative medicine , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom